PERSONALISED CANCER TESTING: AVAILABLE TESTS


Escapee cancer cells in the blood, or 'CTCs' as they are known, can be found by a simple blood test. A CTC Count test finds existing escapee cancer cells (CTCs) in a blood sample and counts them. Monitoring changes in cancer activity over time is made easy with this test... To learn more, please visit our patient or practitioner information page.

Some CTCs can hide in the blood stream for months or years before activating and forming a second tumour. Some CTCs may even resist treatment. This test analyses how a person's CTCs respond when exposed to a recommended chemotherapy regimen or botanical treatment. To learn more, please visit our patient or practitioner information page.

Biomarker analysis can be used to identify receptors that are targets for treatment, to assess the potential for cancer spread or to assist in diagnosis. The identification of certain receptors on a person's CTCs may help practitioners design personalised treatment strategies... To learn more, please visit our patient or practitioner information page.

Tumour Sphere Units tests to see if a person's CTCs can multiply to form microscopic clusters, called Tumour Sphere Units, in the laboratory. CTCs that can form clusters have stem-cell qualities, rendering them more resistant to treatment and capable of forming a second tumour, called a metastasis. To learn more, please visit our patient or practitioner information page.